Advances in Ferroptosis and Glucocorticoid-Induced Osteonecrosis of Femoral Head and Discussion of Related Ferroptosis Genes in Bone Metabolism or Oxidative Stress
Advances in Clinical Medicine,
Год журнала:
2025,
Номер
15(01), С. 1717 - 1730
Опубликована: Янв. 1, 2025
Язык: Английский
Exploring the Molecular Interactions Between Ferroptosis and the Wnt/β-Catenin Signaling Pathway: Implications for Cancer and Disease Therapy
Critical Reviews in Oncology/Hematology,
Год журнала:
2025,
Номер
unknown, С. 104674 - 104674
Опубликована: Фев. 1, 2025
Язык: Английский
The metabolites of gut microbiota: their role in ferroptosis in inflammatory bowel disease
European journal of medical research,
Год журнала:
2025,
Номер
30(1)
Опубликована: Апрель 7, 2025
Inflammatory
bowel
disease
(IBD)
includes
chronic
inflammatory
conditions,
such
as
Crohn's
and
ulcerative
colitis,
characterized
by
impaired
function
of
the
intestinal
mucosal
epithelial
barrier.
In
recent
years,
ferroptosis,
a
novel
form
cell
death,
has
been
confirmed
to
be
involved
in
pathological
process
IBD
is
related
various
changes,
oxidative
stress
inflammation.
Recent
studies
have
further
revealed
complex
interactions
between
microbiome
indicating
that
ferroptosis
an
important
target
for
regulation
gut
microbiota
its
metabolites.
This
article
reviews
significant
roles
microbial
metabolites,
short-chain
fatty
acids,
tryptophan,
bile
IBD.
These
metabolites
participate
influencing
microenvironment,
modulating
immune
responses,
altering
levels,
thereby
exerting
impact
on
development
Treatments
based
are
gradually
becoming
research
hotspot.
Finally,
we
discuss
potential
current
therapeutic
approaches,
including
antibiotics,
probiotics,
prebiotics,
fecal
transplantation,
microbiota,
affecting
improving
symptoms.
With
deeper
understanding
interaction
mechanisms
it
expected
more
precise
effective
treatment
strategies
will
developed
future.
Язык: Английский
Mechanisms of ferroptotic and non-ferroptotic organ toxicity of chemotherapy: protective and therapeutic effects of ginger, 6-gingerol and zingerone in preclinical studies
Naunyn-Schmiedeberg s Archives of Pharmacology,
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 5, 2024
Abstract
Chemotherapy
(CT)
is
one
of
the
flagship
options
for
treatment
cancers
worldwide.
It
involves
use
cytotoxic
anticancer
agents
to
kill
or
inhibit
proliferation
cancer
cells.
However,
despite
its
clinical
efficacy,
CT
triggers
side
effect
toxicities
in
several
organs,
which
may
impact
patient’s
quality
life
and
outcomes.
While
toxicity
consistent
with
non-ferroptotic
mechanisms
involving
oxidative
stress,
inflammation,
mitochondrial
impairment
other
aberrant
signalling
leading
apoptosis
necroptosis,
recent
studies
show
that
ferroptosis,
a
non-apoptotic,
iron-dependent
cell
death
pathway,
also
involved
pathophysiology
organ
toxicity.
provokes
ferroptosis
via
system
Xc
–
/GPX-4/GSH/SLC7A11
axis
depletion,
ferritinophagy,
iron
overload,
lipid
peroxidation
upregulation
ferritin-related
proteins.
Cisplatin
(CP)
doxorubicin
(DOX)
are
common
drugs
indicated
induce
vitro
vivo.
Studies
have
explored
natural
preventive
therapeutic
strategies
using
ginger
rhizome
major
bioactive
compounds,
6-gingerol
(6G)
zingerone
(ZG),
combat
Ginger
extract,
6G
ZG
mitigate
dysfunction
toxicity,
but
their
effects
on
CT-induced
remain
unclear.
Systematic
investigations
are,
therefore,
needed
unfold
roles
ginger,
as
they
potential
prevention
This
review
reveals
ferroptotic
protective
against
CT-induced,
toxicities.
Язык: Английский